| abstract |
A compound inhibiting hepatitis C virus (HCV), a stereoisomer thereof, a tautomeric isomer, an isotope isomer, a prodrug of esterification or amidation, a pharmaceutically acceptable salt, a pharmaceutical composition and its application, A mixture of one or more of the ingredients is provided in an HCV-inhibiting drug-making application. These compounds can also be used to effectively inhibit the hepatitis C virus NS5A and to produce drugs that prevent and / or treat diseases caused by infection of the hepatitis C virus (HCV-NS5A). |